The efficacy of Pasipay drop (Passiflora incarnata) in the treatment of minor depressive disorder

Evaluating the efficacy of Pasipay drop (Passiflora incarnata) in the treatment of minor depressive disorder

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141227020441N8

Enrollment

Registered

2020-02-13

Start date

2020-02-20

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression. Major depressive disorder, single episode, mild

Interventions

Intervention 1: Intervention group: 30 drops hydroalcoholic extract of passiflora incarnata orally daily for 8 weeks. Intervention 2: Control group: 30 drops placebo orally daily for 8 weeks.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Outpatient depress patients HAM-D score =18 18 years old or more without other psychiatric disorder Patients should not have been received psychotropic medications at least 4 weeks before study entry

Exclusion criteria

Exclusion criteria: pregnancy planning for pregnancy breastfeeding serious and unstable disease opium addiction drug or alcohol abuse or dependency history of seizure patients at risk of suicidal attempt history of suicide

Design outcomes

Primary

Measure	Time frame
Score of depression by HAM-D17 questionnaire with score<16. Timepoint: At baseline and at the weeks 2, 4, 6 and 8. Method of measurement: HAM-D17 questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzaneh Foroughinia

Shiraz University of Medical Sciences

foroughinia@sums.ac.ir+98 7132424128233

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026